| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1085463395 |
| P356 | DOI | 10.1038/NRMICRO.2017.44 |
| P698 | PubMed publication ID | 28529325 |
| P50 | author | Guido Kroemer | Q19508945 |
| Laurence Zitvogel | Q28317098 | ||
| Romain Daillère | Q40255955 | ||
| Maria P Roberti | Q93087262 | ||
| Bertrand Routy | Q96103030 | ||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model | Q24654226 | ||
| Role of the microbiome in non-gastrointestinal cancers | Q26747710 | ||
| Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme | Q27665609 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens | Q28075653 | ||
| The hallmarks of aging | Q28131641 | ||
| Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women | Q28251260 | ||
| The three Es of cancer immunoediting | Q28251475 | ||
| Aldara activates TLR7-independent immune defence | Q28286677 | ||
| Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features | Q28595730 | ||
| Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome | Q28645773 | ||
| Longevity in mice is promoted by probiotic-induced suppression of colonic senescence dependent on upregulation of gut bacterial polyamine production | Q28741377 | ||
| Microbial influences in inflammatory bowel diseases | Q29614264 | ||
| Induction of autophagy by spermidine promotes longevity | Q29614498 | ||
| The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis | Q29616351 | ||
| Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells | Q29618126 | ||
| Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation | Q29620116 | ||
| Synchronized cycles of bacterial lysis for in vivo delivery | Q37307560 | ||
| Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. | Q37376599 | ||
| Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. | Q37503122 | ||
| 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment | Q37588284 | ||
| Limitations in doxorubicin production from Streptomyces peucetius | Q37684107 | ||
| An inulin and doxorubicin conjugate for improving cancer therapy | Q37699469 | ||
| EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. | Q38119345 | ||
| Pore-forming toxins: ancient, but never really out of fashion | Q38660364 | ||
| Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance | Q38758370 | ||
| Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions | Q38792334 | ||
| The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer | Q38815561 | ||
| Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism | Q38869873 | ||
| Anti-tumour immune effect of oral administration of Lactobacillus plantarum to CT26 tumour-bearing mice | Q38876416 | ||
| TLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in non-small cell lung cancer | Q38970486 | ||
| Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer | Q38971333 | ||
| Inhibition of Growth and Metastasis of Breast Cancer in Mice by Milk Fermented With Lactobacillus casei CRL 431. | Q39008590 | ||
| Probiotic Lactobacillus acidophilus and L. casei mix sensitize colorectal tumoral cells to 5-fluorouracil-induced apoptosis | Q39720166 | ||
| Differential induction of apoptosis in human colonic carcinoma cells (Caco-2) by Atopobium, and commensal, probiotic and enteropathogenic bacteria: mediation by the mitochondrial pathway. | Q39758852 | ||
| Mediterranean diet and faecal microbiota: a transversal study | Q39802329 | ||
| Relationship between the in vitro response of dendritic cells to Lactobacillus and prevention of tumorigenesis in the mouse | Q39937334 | ||
| Acidic extracellular pH shifts colorectal cancer cell death from apoptosis to necrosis upon exposure to propionate and acetate, major end-products of the human probiotic propionibacteria. | Q40189042 | ||
| Antibiotic-Induced Changes in the Intestinal Microbiota and Disease | Q36948447 | ||
| Beneficial bacteria inhibit cachexia | Q37022010 | ||
| Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors | Q37024095 | ||
| Lactobacillus rhamnosus GG Activation of Dendritic Cells and Neutrophils Depends on the Dose and Time of Exposure | Q37147460 | ||
| The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease | Q37147989 | ||
| Non-absorbable apple procyanidins prevent obesity associated with gut microbial and metabolomic changes | Q37163306 | ||
| The long-term stability of the human gut microbiota | Q37217949 | ||
| Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation | Q37237047 | ||
| Immunogenic cell death in cancer therapy | Q29620118 | ||
| Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma. | Q30358552 | ||
| Compositional data analysis of the microbiome: fundamentals, tools, and challenges | Q31105136 | ||
| The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide | Q31144277 | ||
| Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma | Q33340438 | ||
| Phase I trial of systemic intravenous infusion of interleukin-13-Pseudomonas exotoxin in patients with metastatic adrenocortical carcinoma | Q33421178 | ||
| Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity | Q33554629 | ||
| Cell-bound exopolysaccharide from probiotic bacteria induces autophagic cell death of tumour cells | Q33600111 | ||
| Changes in abundance of oral microbiota associated with oral cancer | Q33700542 | ||
| Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria | Q33957357 | ||
| Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces | Q34101794 | ||
| Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics | Q34311685 | ||
| Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. | Q34429647 | ||
| Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study | Q34438569 | ||
| The potential role of lung microbiota in lung cancer attributed to household coal burning exposures | Q34440594 | ||
| Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinoma | Q34448175 | ||
| Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology | Q34481919 | ||
| Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity | Q34493889 | ||
| The microbiota in adaptive immune homeostasis and disease | Q34533142 | ||
| Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer | Q34539541 | ||
| Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects | Q34542239 | ||
| Cardioprotection and lifespan extension by the natural polyamine spermidine. | Q34544613 | ||
| Acetate dependence of tumors | Q34745657 | ||
| Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress | Q34978574 | ||
| Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. | Q35050169 | ||
| Policy: How to regulate faecal transplants | Q35099908 | ||
| Reprogrammed and transmissible intestinal microbiota confer diminished susceptibility to induced colitis in TMF-/- mice | Q35123366 | ||
| Microbiota modulate tumoral immune surveillance in lung through a γδT17 immune cell-dependent mechanism | Q35191621 | ||
| Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. | Q35197371 | ||
| Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. | Q35419821 | ||
| Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses | Q35446009 | ||
| Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes | Q35489763 | ||
| Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV. | Q35506920 | ||
| Mental health: thinking from the gut. | Q35567682 | ||
| The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition | Q35571641 | ||
| Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study | Q40501515 | ||
| Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial Peptidoglycan | Q40626889 | ||
| Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria. | Q41583397 | ||
| Acetate is a bioenergetic substrate for human glioblastoma and brain metastases | Q41667697 | ||
| Anti-cancer activity of targeted pro-apoptotic peptides | Q41688099 | ||
| Normalizing Microbiota-Induced Retinoic Acid Deficiency Stimulates Protective CD8(+) T Cell-Mediated Immunity in Colorectal Cancer | Q41713919 | ||
| Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis | Q41731982 | ||
| Microbial-derived butyrate: an oncometabolite or tumor-suppressive metabolite? | Q42003419 | ||
| Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome | Q42257409 | ||
| Nontoxic potentiation of cancer chemotherapy by dietary oligofructose or inulin | Q42503968 | ||
| Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. | Q42830585 | ||
| Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanoma | Q43161957 | ||
| Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism | Q43564045 | ||
| Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients | Q44591603 | ||
| Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. | Q45760347 | ||
| Probiotic potential of lactic acid bacteria isolated from fermented dairy milks on antiproliferation of colon cancer cells | Q46179052 | ||
| Does an apple a day keep the oncologist away? | Q46642945 | ||
| Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the attenuation of tumorigenesis in Apc(Min/+) mice | Q47447621 | ||
| The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research | Q47779608 | ||
| Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma | Q48209763 | ||
| Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors | Q48587395 | ||
| Manipulation of the gut microbiota using resistant starch is associated with protection against colitis-associated colorectal cancer in rats. | Q50429019 | ||
| AhR sensing of bacterial pigments regulates antibacterial defence. | Q52874611 | ||
| Butyrate production from high-fiber diet protects against lymphoma tumor. | Q53172774 | ||
| Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer. | Q53214867 | ||
| Orally delivered microencapsulated probiotic formulation favorably impacts polyp formation in APC (Min/+) model of intestinal carcinogenesis. | Q53233595 | ||
| Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. | Q53307288 | ||
| [Influence of Lactobacillus casei on rat bladder carcinogenesis]. | Q53472978 | ||
| Tumor Immunity Produced by the Intradermal Inoculation of Living Tumor Cells and Living Mycobacterium bovis (Strain BCG) | Q54053579 | ||
| Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. | Q54292519 | ||
| Expression of chemokine/cytokine genes and immune cell recruitment following the instillation of Mycobacterium bovis, bacillus Calmette-Guérin or Lactobacillus rhamnosus strain GG in the healthy murine bladder. | Q54549677 | ||
| Antibiotic use predicts an increased risk of cancer | Q57303274 | ||
| Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer | Q57832558 | ||
| Habitual Intake of Lactic Acid Bacteria and Risk Reduction of Bladder Cancer | Q58873671 | ||
| Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer | Q67271686 | ||
| Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group | Q67966831 | ||
| Antitumor activity of Lactobacillus casei in mice | Q71578136 | ||
| Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice | Q72346645 | ||
| Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2 | Q77131178 | ||
| Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium Bovis (bacillus Calmette-Guerin) | Q78413105 | ||
| Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands | Q80591503 | ||
| Effect of hydrogen peroxide of bacterial origin on apoptosis and necrosis of gut mucosa epithelial cells as a possible pathomechanism of inflammatory bowel disease and cancer | Q83180528 | ||
| An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma | Q84963994 | ||
| Engineering Bacillus subtilis for the conversion of the antimetabolite 4-hydroxy-l-threonine to pyridoxine | Q35578887 | ||
| Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study | Q35592471 | ||
| Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial | Q35598580 | ||
| High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals | Q35615264 | ||
| The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA | Q35627540 | ||
| Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity | Q35634752 | ||
| Gut mucosal microbiome across stages of colorectal carcinogenesis. | Q35826754 | ||
| Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy | Q35833912 | ||
| Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota | Q35833921 | ||
| Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity | Q35843279 | ||
| From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease | Q35861517 | ||
| Gut Microbiota Orchestrates Energy Homeostasis during Cold. | Q35861523 | ||
| Genetic and Metabolic Signals during Acute Enteric Bacterial Infection Alter the Microbiota and Drive Progression to Chronic Inflammatory Disease | Q35893552 | ||
| Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. | Q35901034 | ||
| Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis | Q35912366 | ||
| Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses | Q35943509 | ||
| Human symbionts inject and neutralize antibacterial toxins to persist in the gut | Q35950477 | ||
| Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease | Q35964585 | ||
| Microbiome and Anticancer Immunosurveillance | Q35983760 | ||
| The Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites | Q36041507 | ||
| The probiotic approach: an alternative treatment option in urology | Q36044867 | ||
| Repertoire of human gut microbes | Q36056054 | ||
| Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy | Q36068286 | ||
| Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid | Q36069042 | ||
| Microbiome-wide association studies link dynamic microbial consortia to disease | Q36069076 | ||
| Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma | Q36080191 | ||
| Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer | Q36082731 | ||
| Gastrointestinal microbial populations can distinguish pediatric and adolescent Acute Lymphoblastic Leukemia (ALL) at the time of disease diagnosis. | Q36104405 | ||
| Regulatory T-cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis | Q36117973 | ||
| Trial Watch: Experimental Toll-like receptor agonists for cancer therapy | Q36194849 | ||
| A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. | Q36228174 | ||
| Production of butyrate from lysine and the Amadori product fructoselysine by a human gut commensal | Q36419656 | ||
| Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice | Q36658938 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbiome | Q1330402 |
| P304 | page(s) | 465-478 | |
| P577 | publication date | 2017-05-22 | |
| P1433 | published in | Nature Reviews Microbiology | Q1071797 |
| P1476 | title | Anticancer effects of the microbiome and its products | |
| P478 | volume | 15 |
| Q64102200 | A review of 10 years of human microbiome research activities at the US National Institutes of Health, Fiscal Years 2007-2016 |
| Q92586194 | Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors |
| Q98725969 | Bowel inflammation in cancer patients: the microbiome, antibiotics and interleukin-9 |
| Q49594865 | Cancer immunotherapy in 2017: The breakthrough of the microbiota |
| Q90460882 | Characterization of the Anti-Cancer Activity of the Probiotic Bacterium Lactobacillus fermentum Using 2D vs. 3D Culture in Colorectal Cancer Cells |
| Q56889453 | Checkpoint Inhibitors: Conquering Cancer with a Little (T)-Help from Our Microbial Friends |
| Q98165144 | Combination of Detoxified Pneumolysin Derivative ΔA146Ply and Berbamine as a Treatment Approach for Breast Cancer |
| Q55012882 | Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy. |
| Q59161744 | Culturing the human microbiota and culturomics |
| Q91884674 | Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure |
| Q64102188 | Dysbiosis of the Gut Microbiome in Lung Cancer |
| Q99552018 | Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors |
| Q57476181 | Enlisting commensal microbes to resist antibiotic-resistant pathogens |
| Q99578627 | Exploring the food-gut axis in immunotherapy response of cancer patients |
| Q40132867 | Fatty is not that bad: feeding short-chain fatty acids to restrain autoimmunity |
| Q93013941 | Fecal Akkermansia muciniphila Is Associated with Body Composition and Microbiota Diversity in Overweight and Obese Women with Breast Cancer Participating in a Presurgical Weight Loss Trial |
| Q99569163 | Gut Microbes' Impact on Oncogenic Drivers: Location Matters |
| Q92070062 | Gut Microbiome and the Response to Immunotherapy in Cancer |
| Q98178297 | Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage |
| Q61806850 | Gut Microbiota and Cancer: From Pathogenesis to Therapy |
| Q90682838 | Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not？ |
| Q55240704 | Gut microbiome modulates efficacy of immune checkpoint inhibitors. |
| Q57065819 | Gut microbiome profiling and colorectal cancer in African Americans and Caucasian Americans |
| Q57113484 | Gut microbiota bile acid metabolism controls cancer immunosurveillance |
| Q90289012 | Gut microbiota in colorectal cancer: mechanisms of action and clinical applications |
| Q49958101 | Gut microbiota injury in allogeneic haematopoietic stem cell transplantation |
| Q91798966 | Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response |
| Q91971762 | HIV, Cancer, and the Microbiota: Common Pathways Influencing Different Diseases |
| Q92094096 | Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice |
| Q47161100 | How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation. |
| Q89599356 | Immune Responses Raised in an Experimental Colon Carcinoma Model Following Oral Administration of Lactobacillus casei |
| Q92482391 | Ingestion of Non-digestible Carbohydrates From Plant-Source Foods and Decreased Risk of Colorectal Cancer: A Review on the Biological Effects and the Mechanisms of Action |
| Q90702676 | Inhibitory effects of viral infection on cancer development |
| Q90163614 | Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment? |
| Q61446623 | Klebsiella pneumoniae prevents spore germination and hyphal development of Aspergillus species |
| Q64118375 | Mechanistic Insights Into Probiotic Properties of Lactic Acid Bacteria Associated With Ethnic Fermented Dairy Products |
| Q90051711 | Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer |
| Q91321458 | Modulating the microbiome to improve therapeutic response in cancer |
| Q58726363 | Mucosal microbiota of intestinal polyps reveals putative biomarkers of colorectal cancer |
| Q93052035 | Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies |
| Q52928868 | Optically-controlled bacterial metabolite for cancer therapy. |
| Q90746050 | Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy |
| Q40039516 | Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design |
| Q99605164 | Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma |
| Q92383050 | Priorities for the next 10 years of human microbiome research |
| Q55400961 | Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China. |
| Q91670292 | Protective Role of Fecal Microbiota Transplantation on Colitis and Colitis-Associated Colon Cancer in Mice Is Associated With Treg Cells |
| Q55259937 | Proteinaceous Secretory Metabolites of Probiotic Human Commensal Enterococcus hirae 20c, E. faecium 12a and L12b as Antiproliferative Agents Against Cancer Cell Lines. |
| Q64113253 | Role of Gut Microbiota in the Pharmacological Effects of Natural Products |
| Q90225030 | Role of Zinc in Immune System and Anti-Cancer Defense Mechanisms |
| Q49793201 | Starvation, Stress Resistance, and Cancer |
| Q90479321 | Study of the cwaRS-ldcA Operon Coding a Two-Component System and a Putative L,D-Carboxypeptidase in Lactobacillus paracasei |
| Q90218826 | The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases |
| Q89727343 | The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy |
| Q60920745 | The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma |
| Q93016881 | The Role of the Canine Gut Microbiome and Metabolome in Health and Gastrointestinal Disease |
| Q57801565 | The impact of counseling on nutritional status among hematopoietic stem cell recipients: results of a randomized controlled trial |
| Q57997662 | The intimate relationship between gut microbiota and cancer immunotherapy |
| Q92180014 | The microbiome, cancer, and cancer therapy |
| Q91297745 | The next step towards anticancer microbiota therapeutics |
| Q58783075 | The urinary microbiome associated with bladder cancer |
| Q94544748 | Traditional Chinese Medicine and Gut Microbiome: Their Respective and Concert Effects on Healthcare |
| Q99552007 | Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy |
| Q47393365 | Trial watch: Immune checkpoint blockers for cancer therapy |
| Q92642258 | Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies |
Search more.